Mural Oncology Newsroom

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 14 08:34 ET

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 14 07:32 ET

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)

TipRanksNov 14 07:03 ET

Mural Oncology Analyst Ratings

BenzingaNov 14 04:50 ET

H.C. Wainwright Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 13 12:31 ET

Promising Developments in Mural Oncology Plc's Pipeline Reinforce Buy Rating

TipRanksNov 13 12:00 ET

Mural Oncology Price Target Announced at $18.00/Share by HC Wainwright & Co.

Dow JonesOct 17 07:09 ET

Raymond James Initiates Mural Oncology(MURA.US) With Buy Rating, Announces Target Price $18

Moomoo NewsOct 4 09:31 ET

Mural Oncology Analyst Ratings

BenzingaOct 4 07:53 ET

Raymond James Initiates Mural Oncology at Strong Buy With $18 Price Target

MT NewswiresOct 4 07:02 ET

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 26 22:32 ET

Buy Rating Affirmed for Mural Oncology on Strong Potential of Nemvaleukin Therapy and Upcoming Milestones

TipRanksSep 26 22:10 ET

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 9 08:33 ET

Buy Rating Affirmed for Mural Oncology Plc on Promising Clinical Trials and Innovative Cancer Therapies

TipRanksSep 9 08:19 ET

Mural Oncology Analyst Ratings

BenzingaJun 28 12:48 ET

Mural Oncology Analyst Ratings

BenzingaApr 4 06:41 ET